Glycoprotein CA125A (cancer antigen 125, also known as mucin 16 [MUC16]), which is overexpressed in most serous ovarian cancers and is used as a diagnostic serum biomarker, was also assessed (Felder et al., 2014). Here, MUC16 is linked to ovarian serous adenocarcinoma.